In the original version of this article, three authors are missing. The complete list of authors and their current and former (at the time the work was performed) affiliations are provided. The additional authors declare no conflicts of interest. In addition, pharmacodynamics assays performed to obtain absolute plasma concentrations of HGF, VEGF, soluble KDR and soluble Met as described in the original article were incorrectly attributed in the Methods section. The following text… BAbsolute plasma concentrations of HGF, VEGF, soluble KDR and soluble Met were determined by two-site electrochemiluminescent immunoassay as described previously [1] .^… replaces the original text below: BPlasma levels of soluble MET (sMET), HGF, soluble VEGFR2 (sVEGFR2), and VEGF-A were measured using enzyme-linked immunosorbent assay at Pathway Diagnostics, Malibu, California, USA (now Quest Diagnostics Biomarker Lab, Valencia, California, USA) and at Exelixis (for sMET).T he following citation refers to the text added, above. 
